Abstract
The term paraneoplastic syndrome refers to the ability of some tumors to produce signs and symptoms at a distance from the site of the primary tumor or its metastases. Paraneoplastic syndromes may develop before the diagnosis of carcinoma is made. Paraneoplastic syndromes associated with small cell lung cancer (SCLC) include endocrinologic abnormalities secondary to peptide hormone production, and neurologic sequelae due to autoantibody production. This article reviews the common pareneoplastic syndromes that may occur in patients with SCLC.
| Original language | English |
|---|---|
| Pages (from-to) | 65-80 |
| Number of pages | 16 |
| Journal | Chest Surgery Clinics of North America |
| Volume | 7 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1997 |
Fingerprint
Dive into the research topics of 'Paraneoplastic syndromes associated with small cell lung cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver